X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (6) 6
chemotherapy (5) 5
index medicus (5) 5
patients (4) 4
bevacizumab (3) 3
cancer (3) 3
combination (3) 3
humans (3) 3
medicine (3) 3
oxaliplatin (3) 3
pharmacology & pharmacy (3) 3
therapy (3) 3
aged (2) 2
analysis (2) 2
antibodies, monoclonal, humanized - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
cancer patients (2) 2
cancer therapies (2) 2
capecitabine (2) 2
colorectal cancer (2) 2
colorectal neoplasms - drug therapy (2) 2
disease-free survival (2) 2
drug administration schedule (2) 2
efficacy (2) 2
elderly patients (2) 2
fluorouracil (2) 2
fluorouracil - administration & dosage (2) 2
fluorouracil - adverse effects (2) 2
home care (2) 2
leucovorin (2) 2
male (2) 2
management (2) 2
medicine & public health (2) 2
pharmacology/toxicology (2) 2
phase-ii (2) 2
quality-of-life (2) 2
settore med/06 - oncologia medica (2) 2
surgery (2) 2
survival (2) 2
thromboembolism (2) 2
trial (2) 2
tumors (2) 2
1st-line chemotherapy (1) 1
abridged index medicus (1) 1
adherence (1) 1
adult (1) 1
advanced cancer (1) 1
age factors (1) 1
aged patients (1) 1
aged, 80 and over (1) 1
anastrozole (1) 1
angiogenesis inhibitors (1) 1
anorexia (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
aorta (1) 1
aromatase (1) 1
aromatase inhibitors (1) 1
biologic agents (1) 1
biomedical research (1) 1
bioprosthetic valves (1) 1
bisphosphonate (1) 1
blood clots (1) 1
bone metastasis (1) 1
breast cancer (1) 1
camptothecin - administration & dosage (1) 1
camptothecin - adverse effects (1) 1
camptothecin - analogs & derivatives (1) 1
cancer genomics (1) 1
cancer research (1) 1
cancer-patients (1) 1
cardiac & cardiovascular systems (1) 1
cardiovascular disease (1) 1
care and treatment (1) 1
clinical medicine (1) 1
clinical trials (1) 1
clinical trials as topic (1) 1
clinical-trials (1) 1
cohort studies (1) 1
colorectal neoplasms - pathology (1) 1
confidence intervals (1) 1
congenital diseases (1) 1
cost-effectiveness (1) 1
costs (1) 1
data bases (1) 1
deoxycytidine - administration & dosage (1) 1
deoxycytidine - adverse effects (1) 1
deoxycytidine - analogs & derivatives (1) 1
deoxycytidine - therapeutic use (1) 1
deoxyribonucleic acid--dna (1) 1
development and progression (1) 1
discontinuation therapy (1) 1
dosage and administration (1) 1
doublet chemotherapy (1) 1
drug dosages (1) 1
drug therapy (1) 1
dysfunction (1) 1
economic conditions (1) 1
effective therapy management (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Management Issues, ISSN 1973-4832, 10/2015, Volume 4, Issue 1S, pp. 15 - 18
In this article we report a case of a patient with large cell neuroendocrine carcinoma (LCNEC) of the lung. Patients with LCNEC usually have poor prognosis and... 
Octreotide LAR | Large cell neuroendocrine carcinoma (LCNEC) of the lung
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 1/2013, Volume 71, Issue 1, pp. 257 - 264
The addition of bevacizumab to oxaliplatin-based chemotherapy significantly improved progression-free survival (PFS) in patients with metastatic colorectal... 
XELOX | Medicine & Public Health | Maintenance therapy | Colorectal cancer | Oncology | Cancer Research | Pharmacology/Toxicology | Elderly patients | Bevacizumab | LEUCOVORIN | EFFICACY | OXALIPLATIN | FLUOROURACIL | COMBINATION | CHEMOTHERAPY | OLDER PATIENTS | ONCOLOGY | RANDOMIZED PHASE-II | CLINICAL-TRIALS | POOLED ANALYSIS | PHARMACOLOGY & PHARMACY | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Age Factors | Drug Administration Schedule | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Survival Rate | Treatment Outcome | Disease-Free Survival | Fluorouracil - therapeutic use | Deoxycytidine - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Deoxycytidine - adverse effects | Aged | Colorectal Neoplasms - pathology | Deoxycytidine - analogs & derivatives | Hypertension | Care and treatment | Oncology, Experimental | Aged patients | Development and progression | Research | Cancer patients | Chemotherapy | Analysis | Angiogenesis inhibitors | Thromboembolism | Cancer
Journal Article
by McElhinney, Doff B and Aboulhosn, Jamil A and Dvir, Danny and Whisenant, Brian and Zhang, Yulin and Eicken, Andreas and Ribichini, Flavio and Tzifa, Aphrodite and Hainstock, Michael R and Martin, Mary H and Kornowski, Ran and Schubert, Stephan and Latib, Azeem and Thomson, John D.R and Torres, Alejandro J and Meadows, Jeffery and Delaney, Jeffrey W and Guerrero, Mayra E and Salizzoni, Stefano and El-Said, Howaida and Finkelstein, Ariel and George, Isaac and Gewillig, Marc and Alvarez-Fuente, Maria and Lamers, Luke and Cheema, Asim N and Kreutzer, Jacqueline N and Rudolph, Tanja and Hildick-Smith, David and Cabalka, Allison K and Boudjemline, Younes and Milani, Guiti and Bocks, Martin L and Asnes, Jeremy D and Mahadevan, Vaikom and Himbert, Dominique and Goldstein, Bryan H and Fagan, Thomas E and Cheatham, John P and Momenah, Tarek S and Kim, Dennis W and Colombo, Antonio and Ancona, Marco and Butera, Gianfranco and Forbes, Thomas J and Horlick, Eric and Pedra, Carlos and Alfonsi, Jacopo and Jones, Thomas K and Foerster, Susan and Shahanavaz, Shabana and Crittendon, Ivory and Schranz, Dietmar and Qureshi, Athar and Thomas, Martyn and Kenny, Damien P and Hoyer, Mark and Bleiziffer, Sabine and Kefer, Joelle and Testa, Luca and Gillespie, Matthew and Khan, Danyal and Pass, Robert H and Abdel-Wahab, Mohamed and Wijeysundera, Harindra and Casselman, Filip and Moe, Tabitha and Hayes, Nicholas and Alli, Oluseun and Nayak, Keshav R and Patel, Priti and Piazza, Nicolo and Seaman, Cameron and Windecker, Stephan and Kuo, James and Ing, Frank F and Makkar, Raj R and Greif, Martin and Cerillio, Alfredo G and Champagnac, Didier and Nietlispach, Fabian and Maisano, Francesco and Treede, Hendrik and Seiffert, Moritz and Teles, Rui Campante and Feuchtner, Gudrun and Bonaros, Nikolaos and Bruschi, Giuseppe and Pesarini, Gabriele and VIVID Registry
Journal of the American College of Cardiology, ISSN 0735-1097, 01/2019, Volume 73, Issue 2, pp. 148 - 157
Journal Article
by De Placido, Sabino and Gallo, Ciro and De Laurentiis, Michelino and Bisagni, Giancarlo and Arpino, Grazia and Sarobba, Maria Giuseppa and Riccardi, Ferdinando and Russo, Antonio and Del Mastro, Lucia and Cogoni, Alessio Aligi and Cognetti, Francesco and Gori, Stefania and Foglietta, Jennifer and Frassoldati, Antonio and Amoroso, Domenico and Laudadio, Lucio and Moscetti, Luca and Montemurro, Filippo and Verusio, Claudio and Bernardo, Antonio and Lorusso, Vito and Gravina, Adriano and Moretti, Anna and Moretti, Gabriella and Lauria, Rossella and Lai, Antonella and Mocerino, Carmela and Rizzo, Sergio and Nuzzo, Antonio and Nuzzo, Francesco and Carlini, Paolo and Perrone, Francesco and Accurso, Antonello and Agostara, Biagio and Aieta, Michele and Alabiso, Oscar and Alicicco, Maria Grazia and Amadori, Dino and Amaducci, Laura and Amiconi, Gianna and Antuzzi, Giustino and Ardine, Mara and Ardizzoia, Antonio and Aversa, Caterina and Badalamenti, Giuseppe and Barni, Sandro and Basurto, Carlo and Berardi, Rossana and Bergamasco, Cinzia and Bidoli, Paolo and Bighin, Claudia and Biondi, Edoardo and Boni, Corrado and Borgonovo, Karen and Botta, Mario and Bravi, Stefano and Bruzzi, Paolo and Buono, Giuseppe and Butera, Alfredo and Caldara, Alessia and Candeloro, Giampiero and Cappelletti, Claudia and Cardalesi, Cinzia and Carfora, Elisabetta and Cariello, Anna and Carrozza, Francesco and Cartenì, Giacomo and Caruso, Michele and Casadei, Virginia and Casanova, Claudia and Castori, Luigi and Cavanna, Luigi and Cavazzini, Giovanna and Cazzaniga, Marina and Chilelli, Mario and Chiodini, Paolo and Chiorrini, Silvia and Ciardiello, Fortunato and Ciccarese, Mariangela and Cinieri, Saverio and Clerico, Mario and Coccaro, Mariarosa and Comande, Mario and Corbo, Claudia and Cortino, Giuseppina and Cusenza, Stefania and Daniele, Gennaro and D'arco, Alfonso Maria and D'auria, Giuliana and Dazzi, Claudio and De Angelis, Carmine and de Braud, Filippo and De Feo, Gianfranco and De Matteis, Andrea and De Tursi, Michele and Di Blasio, Anna and di Lucca, Giuseppe and Di Lullo, Liberato and Di Rella, Francesca and Di Renzo, Gianfranco and ... and GIM Investigators
The Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 474 - 485
Uncertainty exists about the optimal schedule of adjuvant treatment of breast cancer with aromatase inhibitors and, to our knowledge, no trial has directly... 
SYSTEM | THERAPY | EFFICACY | ONCOLOGY | FOLLOW-UP | POSTMENOPAUSAL WOMEN | COMBINATION | AROMATASE INHIBITORS | Breast cancer | Product development | Tamoxifen | Analysis
Journal Article
CANCERS, ISSN 2072-6694, 04/2019, Volume 11, Issue 4, p. 578
Patients older than 75 years of age are usually excluded from metastatic colorectal cancer studies based on a combination chemotherapy containing oxaliplatin.... 
elderly patients | colorectal cancer | INTERNATIONAL-SOCIETY | BEVACIZUMAB | 1ST-LINE CHEMOTHERAPY | OLDER | PHASE-II | OPEN-LABEL | LIVER METASTASES | CAPECITABINE | doublet chemotherapy | ONCOLOGY | RECOMMENDATIONS | oxaliplatin | ELDERLY-PATIENTS
Journal Article
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, ISSN 1178-203X, 2011, Volume 7, Issue default, pp. 387 - 392
Patient-centered home care is a new model of assistance, which may be integrated with more traditional hospital-centered care especially in selected groups of... 
TRIAL | home care | MANAGEMENT | COSTS | biologic agents | HEALTH CARE SCIENCES & SERVICES | cancer | chemotherapy | Patients | Review
Journal Article
Investigational New Drugs, ISSN 0167-6997, 10/2012, Volume 30, Issue 5, pp. 1978 - 1983
Journal Article
Journal of Bone Oncology, ISSN 2212-1374, 2012, Volume 1, Issue 2, pp. 35 - 39
Background: Several studies have emphasized the importance of the maintenance of bone health in a comprehensive cancer care. However, no survey about approach... 
Bisphosphonate | Bone metastasis | Survey | Skeletal-related event
Journal Article
Journal of Chemotherapy, ISSN 1120-009X, 02/2010, Volume 22, Issue 1, pp. 48 - 53
In the era of targeted therapies and combined modalities of treatment, scientific research plays a role of paramount importance in improving knowledge of... 
impact factor | Sicily | Scientific research | Impact factor | SURVIVAL | CANCER-PATIENTS | ONCOLOGY | PHARMACOLOGY & PHARMACY | QUALITY-OF-LIFE | OUTCOMES | TERM | RANDOMIZED CLINICAL-TRIALS | Medical Oncology | Biomedical Research | Clinical Trials as Topic | Humans | Journal Impact Factor
Journal Article
2000, Saggi, ISBN 9788872846353, Volume 53, 143
Book
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.